Hologic to Acquire Diagenode for ~$159M

 Hologic to Acquire Diagenode for ~$159M

Hologic to Acquire Diagenode for ~$159M

Shots:

  • Hologic to acquire Diagenode for ~$159M. The transaction will expand and diversifies Hologic’s diagnostic business across test menu, customer segments and geography
  • The acquisition will strengthen Hologic’s molecular diagnostics business by expanding international its capabilities and allow it to offer a broader more differentiated test menu
  • Diagenode and Hologic previously collaborated to develop Hologic’s Panther Fusion assays for detecting streptococcus and Bordetella

Click here ­to­ read full press release/ article | Ref: Businesswire | Image: Hologic

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post